⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3059067 | 1.00 | — | — | |
| SCHEMBL11971581 | 0.80 | TP53 (0.36) | — | |
| SCHEMBL15636111 | 0.79 | — | — | |
| SCHEMBL849765 | 0.79 | — | — | |
| SCHEMBL6265677 | 0.79 | — | — | |
| SCHEMBL442850 | 0.79 | — | — | |
| SCHEMBL25388256 | 0.77 | — | — | |
| SCHEMBL28880989 | 0.77 | CYP2D6 (0.40) | — | |
| SCHEMBL497756 | 0.75 | CYP1A2 (0.43) | — | |
| SCHEMBL7613000 | 0.75 | CYP1A2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240336654-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | Universität Zürich (CH) | 2024-10-10 | — | — | US | claimed |
| US-20240228555-A9 | ANTIMICROBIAL PEPTIDOMIMETICS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2024-07-11 | — | — | US | claimed |
| EP-4380689-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | Basilea Pharmaceutica International AG, Allschwil (CH) | 2024-06-12 | — | — | EP | claimed |
| CN-118043339-A | Antimicrobial peptidomimetics | 巴斯利尔药物阿尔施维尔国际股份公司 | 2024-05-14 | — | — | CN | claimed |
| US-20240132553-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | SPEXIS AG (CH) | 2024-04-25 | — | — | US | claimed |
| US-20230295234-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | SPEXIS AG (CH) | 2023-09-21 | — | — | US | claimed |
| EP-4214221-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | Spexis AG (CH) | 2023-07-26 | — | — | EP | claimed |
| EP-4214220-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | Spexis AG (CH) | 2023-07-26 | — | — | EP | claimed |
| CN-115989237-A | Antimicrobial peptidomimetics | 斯派西斯公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115989236-A | Antimicrobial peptidomimetics | 斯派西斯公司 | 2023-04-18 | — | — | CN | claimed |
| WO-2023012319-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | SPEXIS AG (CH) | 2023-02-09 | — | — | WO | claimed |
| WO-2022028737-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | POLYPHOR AG (CH) | 2022-02-10 | — | — | WO | claimed |
| EP-2559753-B1 | Microorganism having enhanced L-valine productivity and method for producing L-valine using the same | CJ CHEILJEDANG CORP (KR) | 2013-12-04 | — | — | EP | claimed |
| US-8465962-B2 | Microorganism having enhanced L-valine productivity and method for producing L-valine using the same | CJ CHEILJEDANG CORPORATION (KR) | 2013-06-18 | — | — | US | claimed |
| WO-2013024947-A1 | MICROORGANISM HAVING ENHANCED L-VALINE PRODUCTIVITY AND METHOD FOR PRODUCING L-VALINE USING THE SAME | CJ CHEILJEDANG CORPORATION (KR) | 2013-02-21 | — | — | WO | claimed |
| US-20130045511-A1 | MICROORGANISM HAVING ENHANCED L-VALINE PRODUCTIVITY AND METHOD FOR PRODUCING L-VALINE USING THE SAME | CJ CHEILJEDANG CORPORATION (KR) | 2013-02-21 | — | — | US | claimed |
| EP-2559753-A1 | Microorganism having enhanced L-valine productivity and method for producing L-valine using the same | CJ CheilJedang Corporation (KR) | 2013-02-20 | — | — | EP | claimed |
| US-20240336654-A1 | ANTIMICROBIAL PEPTIDOMIMETICS | Universität Zürich (CH) | 2024-10-10 | — | — | US | disclosed |
| WO-2001076616-A1 | TAMANDARIN AND DIDEMNIN ANALOGS AND METHODS OF MAKING AND USING THEM | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2001-10-18 | — | — | WO | disclosed |
| US-4230854-A | HYPOTENSIVE AGENTS; ADRENERGIC BLOCKING AGENTS | SOCIETA FARMACEUTICI ITALIA S.P.A. (IT) | 1980-10-28 | — | — | US | disclosed |